Filing Details

Accession Number:
0000899243-18-022295
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2018-08-14 16:35:26
Reporting Period:
2017-07-05
Accepted Time:
2018-08-14 16:35:26
Original Submission Date:
2017-07-05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1420565 Aileron Therapeutics Inc ALRN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1709654 Scott Kapnick C/O Aileron Therapeutics, Inc.
281 Albany Street
Cambridge MA 02139
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-07-05 66,666 $15.00 66,666 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Footnotes
  1. The amount of securities previously reported as beneficially owned by the Reporting Person inadvertently aggregated shares that the Reporting Person indirectly beneficially owned with shares that the Reporting Person directly beneficially owned following the transaction reported on the original Form 4. The correct number of shares that the Reporting Person indirectly beneficially owned following this transaction was 66,666 shares.
  2. These shares are directly owned by Jake86 LLC, for which the Reporting Person serves as investment manager. The Reporting Person disclaims beneficial ownership of the shares held by Jake86 LLC, except to the extent of his indirect pecuniary interest therein.